We are live on ! Find out more
GMDA

Gamida Cell Ltd. Ordinary Shares

Delisted

GMDA was delisted on the 5th of April, 2024.

59 hedge funds and large institutions have $84M invested in Gamida Cell Ltd. Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 18 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more capital invested

Capital invested by funds: $45.8M → $84M (+$38.2M)

43% more call options, than puts

Call options by funds: $827K | Put options by funds: $577K

6% less funds holding

Funds holding: 6359 (-4)

17% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 18

33% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 9

Holders
59
Holders Change
-4
Holders Change %
-6.35%
% of All Funds
0.93%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
15
Reduced
18
Closed
9
Calls
$827K
Puts
$577K
Net Calls
+$250K
Net Calls Change
+$298K
Name Holding Trade Value Shares
Change
Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$21.3M +$2.56M +764,985 +18%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$19M -$54.4K -16,241 -0.4%
IBT
3
International Biotechnology Trust
United Kingdom
$9.98M
RSCM
4
Rock Springs Capital Management
Maryland
$8.94M
HCM
5
Highbridge Capital Management
New York
$4.15M +$679K +202,456 +25%
AIM
6
ARK Investment Management
Florida
$3.54M +$343K +102,432 +14%
JP Morgan Chase
7
JP Morgan Chase
New York
$3.04M +$278K +83,009 +13%
Mariner
8
Mariner
Kansas
$2.58M +$160K +47,587 +8%
LNWTC
9
Laird Norton Wetherby Trust Company
Washington
$2.19M
MIH
10
Meitav Investment House
Israel
$1.78M
BlackRock
11
BlackRock
New York
$1.46M -$43.6K -13,018 -4%
Marshall Wace
12
Marshall Wace
United Kingdom
$770K +$264K +78,851 +74%
YAVAPFMC
13
Yahav Achim Ve Achayot - Provident Funds Management Company
Israel
$721K
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$585K -$379K -112,929 -44%
SFI
15
Susquehanna Fundamental Investments
Pennsylvania
$530K -$23K -6,867 -5%
Morgan Stanley
16
Morgan Stanley
New York
$517K +$164K +48,824 +65%
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
$338K -$144K -42,896 -35%
State Street
18
State Street
Massachusetts
$310K +$11.1K +3,322 +5%
Simplex Trading
19
Simplex Trading
Illinois
$261K +$96.5K +28,781 +84%
Victory Capital Management
20
Victory Capital Management
Texas
$256K
PTP
21
Platform Technology Partners
New York
$231K +$1.68K +500 +0.9%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$151K +$79.5K +23,717 +187%
Citadel Advisors
23
Citadel Advisors
Florida
$135K -$88.9K -26,508 -45%
IC
24
Ikarian Capital
Texas
$135K +$5.56K +1,660 +5%
PF
25
Phoenix Financial
Israel
$121K

GMDA Hedge Fund Activity: Q1 2022 in Review

59 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Gamida Cell Ltd. Ordinary Shares (GMDA) for Q1 2022, worth a combined $84M — up 83% from $45.8M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of GMDA and 6 opened new positions — a net loss of 3 holders — while 18 trimmed existing stakes and 15 added.

The largest buyer was Federated Hermes, adding an estimated $2.56M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $1.55M sold.

  • 59 institutional investors held Gamida Cell Ltd. Ordinary Shares (GMDA) as of Q1 2022, down from 63 in Q4 2021.
  • Funds reported $84M of Gamida Cell Ltd. Ordinary Shares stock for Q1 2022, up 83% quarter-over-quarter.
  • 6 funds opened new Gamida Cell Ltd. Ordinary Shares positions in Q1 2022 and 9 closed out, a net change of -3 holders.
  • The largest Gamida Cell Ltd. Ordinary Shares buyer in Q1 2022 was Federated Hermes, an estimated $2.56M added.
  • The largest Gamida Cell Ltd. Ordinary Shares seller in Q1 2022 was Baker Bros. Advisors, an estimated $1.55M sold.

Based on aggregated 13F filings for Q1 2022.